BGMS

Cyclacel Pharmaceuticals

BGMS • NASDAQ

Cyclacel Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sing Ee Wong, with a market cap of $4.9M.

CEOSing Ee Wong
Market Cap$4.9M
Biotechnology
Healthcare
Employees12.0
Websitecyclacel.com

Next Earnings

Upcoming earnings announcement for Cyclacel Pharmaceuticals

Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (12:00 AM New York)
Fiscal Period
Q1 2026

Earnings History

Past 2 earnings reports for Cyclacel Pharmaceuticals

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Mar 30, 2026Q4 2025
-$2.21
—
$666.0K
——
Nov 13, 2025Q3 2025
-$1.31
—
$81.0K
——

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.